Conditions & Treatments

Home » Conditions & Treatments

The physicians at Retina Northwest specialize in the diseases which affect the structures in the back of the eye: the retina and vitreous. The links provided may be useful to learn more about these conditions.  All related informational video content is courtesy of the American Academy of Ophthalmology.

Useful Links:

National Eye Institute
The American Society of Retina Specialists
The American Academy of Ophthalmology 
Providence MyChart 
Legacy MyHealth 

Keeping Your Retina Healthy

Para ver el ví­deo en español, haga clic aquí.

Age-Related Macular Degeneration (AMD)

Para ver el vídeo en español, haga clic aquí.

Diabetic Retinopathy

Para ver el ví­deo en español, haga clic aquí.

Retinal Tears and Detachment

Para ver el ví­deo en español, haga clic aquí.

Low Vision

Para ver el ví­deo en español, haga clic aquí.

Retina Northwest does not provide low vision rehabilitation but can refer patients to appropriate services.

Home
Our Physicians & Staff
Useful Links
Your Visit
Contact Us
Careers
Privacy Policy
Terms of Use
Administrative Office
4225 NE St. James Road
Vancouver, WA 98663
503-274-2121 or 1-800-654-7765
Fax: 866-843-7990
Clinic Locations
© 2024 Retina Northwest. Portland Web Design by Watermelon Web Works
Accessibility by WAH

 ATTENTION: ALL RETINA NORTHWEST PATIENTS

  For the health and safety of all patients and staff, note our current guidelines (subject to change without notice).

· During the injection process, MASKS ARE REQUIRED FOR PATIENTS AND ALL OTHERS IN THE PROCEDURE ROOM.

· One family member/friend is allowed to accompany the patient.

 

Meet our new physician, Dr. Janani Singaravelu Polder, who joined Retina Northwest on October 1, 2024.

Dr. Polder began her education at The University of Pennsylvania in Philadelphia, PA, earning a Bachelor of Arts degree in Neuroscience and South Asia Studies, followed by a Master of Medical Science degree at Drexel University College of Medicine. She was subsequently awarded the Fulbright Student Research Grant to conduct Public Health research in India. Upon returning, she earned a Doctor of Medicine degree at The Ohio State University College of Medicine. She was selected for the prestigious NIH Medical Research Scholars Program, where she conducted basic science retina research at the National Eye Institute. Her postgraduate training began with her transitional year internship at Mt. Carmel Health System in Columbus, OH, followed by Ophthalmology residency at the Washington University School of Medicine in St. Louis. She completed Ophthalmic Oncology fellowship at the renowned Cole Eye Institute at the Cleveland Clinic then joined The Retina Group of Washington where she was a Surgical Vitreoretinal Fellow.



Good Days Chronic Disease Fund: Lack of Funding for 2025

In the past, patients with Medicare and Medicare Advantage plans were eligible to enroll in the Good Days program, a national non-profit charitable organization, that assisted with offsetting the cost of the patient responsibility coinsurance for injections based on financial need.

Unfortunately, at this time, Good Days has not received adequate funding in order to continue to provide assistance for all eligible patients.

As a result, unless there is additional funding received, moving forward, patients will be responsible for their coinsurance amount at the time of their visit. As participating providers in the Medicare program, Retina Northwest is required by federal law to collect unmet deductible, and coinsurance amounts for Medicare and Medicare Advantage plan beneficiaries.

Retina Northwest recognizes the importance of continued treatment for our patients – if you are unable to afford your coinsurance, please do not skip your scheduled appointment – there may be other treatment options available.

If you would like to check your funding status you may follow this link: https://mygooddays.org/check-status/. Most of our patients are covered under the Macular Disease program but if you cannot find your account, you can check under the Retinal Disease program.